GWSG
OYST

GPS Wealth Strategies Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

GPS Wealth Strategies Group’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,052
Closed -$12K – 1172
2022
Q3 		$12K Sell
2,052
-82
-4% -$514 ﹤0.01% 736
2022
Q2 		$9K Buy
+2,134
New +$12.1K ﹤0.01% 797

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GPS Wealth Strategies Group's OYST Position: Q4 2022 in Review

GPS Wealth Strategies Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 2,052 shares — an estimated $12K sold.

GPS Wealth Strategies Group first reported a position in OYST in Q2 2022 and held it in 2 quarters. The position peaked at $12K in Q3 2022. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

  • GPS Wealth Strategies Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 2,052 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $12K.
  • GPS Wealth Strategies Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • GPS Wealth Strategies Group's Oyster Point Pharma, Inc. Common Stock position peaked at $12K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2022, filed 27 Jan 2023.